Drug Shortage Report for SODIUM BICARBONATE INJECTION, USP

Last updated on 2021-01-12 History
Report ID 128660
Drug Identification Number 02486636
Brand name SODIUM BICARBONATE INJECTION, USP
Common or Proper name Sodium Bicarbonate Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) SODIUM BICARBONATE
Strength(s) 84MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 8.4%, 50 mEq (mmol), 50 mL Vial
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-11-30
Actual start date
Estimated end date 2021-01-04
Actual end date 2021-01-11
Shortage status Resolved
Updated date 2021-01-12
Company comments Fresenius Kabi Canada Ltd. is pleased to advise that our Sodium Bicarbonate Injection, USP 8.4% 50 mEq (mmol) Vial 50 mL will be available at Ontario distribution centers today, Monday, January 11, 2021 and at all other distribution centers by Friday, January 15, 2021.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-11-20 English Compare
v2 2020-11-20 French Compare
v3 2020-12-01 English Compare
v4 2021-01-11 English Compare
v5 2021-01-11 French Compare
v6 2021-01-12 English Compare

Showing 1 to 6 of 6